Neuropsychiatric symptoms in the course of Wegener's granulomatosis

Exome sequencing in dementia with Lewy bodies.

Translational psychiatry·2016

APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.

Age and ageing·2009

Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.

Neurobiology of aging·2009

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype.

Journal of neurology, neurosurgery, and psychiatry·2008

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.

Dementia and geriatric cognitive disorders·2008

Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

Neurology·2008

PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophy.

Journal of neurology, neurosurgery, and psychiatry·2026

Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.

Journal of neurology, neurosurgery, and psychiatry·2026

Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrence.

Journal of neurology, neurosurgery, and psychiatry·2026

Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Journal of neurology, neurosurgery, and psychiatry·2026

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

Journal of neurology, neurosurgery, and psychiatry·2026

MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.

Journal of neurology, neurosurgery, and psychiatry·2026

Alpha-synuclein: The main actor at the first Patagonia Synuclein workshop.

Journal of Parkinson's disease·2026

Targeting Mitochondrial Redox Signaling Promotes Neuroregeneration and Functional Recovery in a Multiple Sclerosis Model.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Evaluation of corneal and lens densitometry using Scheimpflug tomography in neurofibromatosis type 1 patients without clinical ocular involvement.

Ophthalmic genetics·2026

Identification of Usutu virus in blood donors as part of molecular screening for West Nile virus, France, 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Plasma and CSF neurofilament light chain measured by Simoa and Lumipulse: an inter-platform comparison across neurological disorders.

Clinical chemistry and laboratory medicine·2026

Cryptic Presentations of Neurologic Wilson Disease With ATP7B Peptide Assessments.

Neurology. Genetics·2026

Neuropsychiatric symptoms in the course of Wegener's granulomatosis

Related Experiment Videos

Related Concept Videos

Exome sequencing in dementia with Lewy bodies.

APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.

Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype.

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.

Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophy.

Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.

Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrence.

Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.

Alpha-synuclein: The main actor at the first Patagonia Synuclein workshop.

Targeting Mitochondrial Redox Signaling Promotes Neuroregeneration and Functional Recovery in a Multiple Sclerosis Model.

Evaluation of corneal and lens densitometry using Scheimpflug tomography in neurofibromatosis type 1 patients without clinical ocular involvement.

Identification of Usutu virus in blood donors as part of molecular screening for West Nile virus, France, 2023.

Plasma and CSF neurofilament light chain measured by Simoa and Lumipulse: an inter-platform comparison across neurological disorders.

Cryptic Presentations of Neurologic Wilson Disease With ATP7B Peptide Assessments.

Neuropsychiatric symptoms in the course of Wegener's granulomatosis

Related Experiment Videos

Related Concept Videos

Related Articles